|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-2-19
|
|
pubmed:abstractText |
Renal anemia is a serious complication of chronic kidney disease (CKD) and accelerates its progress. Recombinant human erythropoietin (rHuEPO) therapy not only improves anemia but also has a renoprotective effect. This study aimed to determine whether treatment with rHuEPO can retard the initiation of hemodialysis (HD) in patients with CKD.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0385-2385
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
58-65
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20166543-Aged,
pubmed-meshheading:20166543-Aged, 80 and over,
pubmed-meshheading:20166543-Anemia,
pubmed-meshheading:20166543-Disease Progression,
pubmed-meshheading:20166543-Erythropoietin,
pubmed-meshheading:20166543-Female,
pubmed-meshheading:20166543-Humans,
pubmed-meshheading:20166543-Kaplan-Meier Estimate,
pubmed-meshheading:20166543-Kidney Failure, Chronic,
pubmed-meshheading:20166543-Male,
pubmed-meshheading:20166543-Middle Aged,
pubmed-meshheading:20166543-Recombinant Proteins,
pubmed-meshheading:20166543-Renal Dialysis,
pubmed-meshheading:20166543-Retrospective Studies,
pubmed-meshheading:20166543-Survival Rate,
pubmed-meshheading:20166543-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
[Retardation of hemodialysis by recombinant human erythropoietin in patients with chronic kidney disease].
|
|
pubmed:affiliation |
Department of Drug Information and Communication, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
